These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 24156901
61. Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Malla AK, Bodnar M, Joober R, Lepage M. Schizophr Res; 2011 Jan; 125(1):13-20. PubMed ID: 21059482 [Abstract] [Full Text] [Related]
62. The association of striatal volume and positive schizotypy in healthy subjects: intelligence as a moderating factor. Meller T, Ettinger U, Grant P, Nenadić I. Psychol Med; 2020 Oct; 50(14):2355-2363. PubMed ID: 31530329 [Abstract] [Full Text] [Related]
63. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. Witthaus H, Mendes U, Brüne M, Ozgürdal S, Bohner G, Gudlowski Y, Kalus P, Andreasen N, Heinz A, Klingebiel R, Juckel G. J Psychiatry Neurosci; 2010 Jan; 35(1):33-40. PubMed ID: 20040244 [Abstract] [Full Text] [Related]
64. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C. Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856 [Abstract] [Full Text] [Related]
65. Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients. Goghari VM, Smith GN, Honer WG, Kopala LC, Thornton AE, Su W, Macewan GW, Lang DJ. Schizophr Res; 2013 Sep; 149(1-3):149-55. PubMed ID: 23830856 [Abstract] [Full Text] [Related]
67. Insular cortex abnormalities in psychotic major depression: relationship to gender and psychotic symptoms. Cohen JD, Nichols T, Keller J, Gomez RG, Schatzberg AF, Reiss AL. Neurosci Res; 2013 Apr; 75(4):331-9. PubMed ID: 23471015 [Abstract] [Full Text] [Related]
68. Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders. Mittal VA, Tessner KD, Trottman HD, Esterberg M, Dhrub SH, Simeonova DI, McMillan AL, Murphy E, Saczawa ME, Walker EF. J Abnorm Psychol; 2007 May; 116(2):260-7. PubMed ID: 17516759 [Abstract] [Full Text] [Related]
71. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Dazzan P, Soulsby B, Mechelli A, Wood SJ, Velakoulis D, Phillips LJ, Yung AR, Chitnis X, Lin A, Murray RM, McGorry PD, McGuire PK, Pantelis C. Schizophr Bull; 2012 Sep; 38(5):1083-91. PubMed ID: 21518921 [Abstract] [Full Text] [Related]
72. Self-reported cognitive distortions in the psychosis continuum: A Polish 18-item version of the Davos Assessment of Cognitive Biases Scale (DACOBS-18). Gawęda Ł, Prochwicz K, Krężołek M, Kłosowska J, Staszkiewicz M, Moritz S. Schizophr Res; 2018 Feb; 192():317-326. PubMed ID: 28601498 [Abstract] [Full Text] [Related]
75. Progressive structural brain changes during development of psychosis. Ziermans TB, Schothorst PF, Schnack HG, Koolschijn PC, Kahn RS, van Engeland H, Durston S. Schizophr Bull; 2012 May; 38(3):519-30. PubMed ID: 20929968 [Abstract] [Full Text] [Related]
76. Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity. Takahashi T, Nakamura M, Sasabayashi D, Komori Y, Higuchi Y, Nishikawa Y, Nishiyama S, Itoh H, Masaoka Y, Suzuki M. Eur Arch Psychiatry Clin Neurosci; 2018 Oct; 268(7):689-698. PubMed ID: 29071372 [Abstract] [Full Text] [Related]
78. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms. Lee AH, Weintraub D. Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352 [Abstract] [Full Text] [Related]